GSK pulls one lot of Infanrix vaccine on contamination worries; Irish output sinks on 35% drop in pharma production;

@FiercePharma: Are you ready, Humira? Pfizer nabs FDA blessing for blockbuster hopeful Xeljanz, for rheumatoid arthritis. Story | Follow @FiercePharma

> GlaxoSmithKline ($GSK) pulled another lot of its Infanrix Hexa vaccine because of potential microbial contamination; the recall follows a similar move in Australia. Report

> Pharma cuts in Ireland are taking their toll; the country's manufacturing output dropped 14% as drugmakers' production dropped by 35%. Report

> Sanofi ($SNY) CEO Christopher Viehbacher was elected president of EFPIA, Europe's pharma trade group, where he will replace GlaxoSmithKline Chief Andrew Witty. Report

> Sanofi priced a new bond issue, aiming to raise €750 million ($957 million) from the sale. Report

> Canada's top court is preparing to decide whether Pfizer's ($PFE) Viagra patent is valid, in a case that could sway patent law toward--or away from--transparency, experts say. Report

> The Taro Pharmaceuticals ($TARO) feud with Sun Pharma continues with accusations of under-reported sales, as Taro shareholders prepare to vote on a proposed merger with the Indian company. Report

Medical Device News

 @FierceMedDev: BSX study shows improved defibrillator programming reduces unnecessary jolts as well as risk of death. More | Follow @FierceMedDev

 @MarkHFierce: BD ended its 2012 fiscal year on a down note. But CE Forlenza qualifies it as a "solid finish." News | Follow @MarkHFierce

 @DamianFierce: Medical device manufacturer Onyx got snapped up for $43.25M by Sparton. Story | Follow @DamianFierce

> Mindray tanks on disappointing Q3. Article

> Medtronic-backed study supports greater use of CRT pacemakers. Story

> Study: Valves & stents often win FDA nod without proving they improve care. Item

Biotech News

 @FierceBiotech: Test could detect a range of cancers weeks before symptoms. More | Follow @FierceBiotech

 @JohnCFierce: Are clinical trial investigators guilty of mission creep? Report | Follow @JohnCFierce

 @RyanMFierce: Maverix enters genomics software game with Silicon Valley sizzle. More | Follow @RyanMFierce

> Roche, ImmunoGen gain speedy review for T-DM1 breast cancer breakthrough. News

> FDA hands Pfizer blockbuster approval for rheumatoid arthritis drug tofacitinib. Story

Drug Delivery News

> Hydrogel time bombs set off explosive drug release. Story

> Novartis submits COPD combination inhaler in Japan. Item

> $1M Gates Foundation grant to formulate lifesaving oxytocin. News

Biomarkers News

> Bowel cancer biomarkers from Down Under catch U.S. attention. Item

> Blood protein tags progression in ALS. Article

> Phase III finding points to masitinib CDx for pancreatic cancer. Story

> Breast cancer biomarkers predict tamoxifen response. Report

> Simple blood count points to survival in aggressive skin cancer. News

And Finally... Performance-enhancing drugs aren't limited to athletes, creating ethical dilemmas at the office. Report